The United States of America as represented by the Secretary of the Army

United States of America

Back to Profile

1-20 of 20 for The United States of America as represented by the Secretary of the Army Sort by
Query
Patent
Canada - CIPO
Aggregations Reset Report
Date
2024 1
2023 1
2022 2
2021 4
Before 2020 12
IPC Class
A61P 31/14 - Antivirals for RNA viruses 4
C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses 3
A61B 17/132 - Tourniquets 2
A61K 39/42 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum viral 2
C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus 2
See more
Status
Pending 11
Registered / In Force 9
Found results for  patents

1.

VACCINES AGAINST CORONAVIRUSES

      
Document Number 03265295
Status Pending
Filing Date 2023-08-18
Open to Public Date 2024-02-29
Owner
  • UNITED STATES OF AMERICA, as represented BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (USA)
  • SANOFI PASTEUR INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES, as represented BY THE SECRETARY OF THE ARMY (USA)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
Inventor
  • Joyce, Michael Gordon
  • Modjarrad, Kayvon
  • Thomas, Paul
  • Chen, Wei-Hung
  • Hajduczki, Agnes
  • Rolland, Morgane
  • Lewitus, Eric
  • Anosova, Natalie
  • Clark, Nicholas
  • Davidson, Philip
  • Lecouturier, Valerie
  • Ustyugova, Irina V.
  • Warren, William
  • Wu, Monica Z.
  • Douek, Daniel
  • Koup, Richard

IPC Classes  ?

2.

IGA MONOCLONAL ANTIBODIES FOR TREATING FLAVIVIRUS INFECTION

      
Document Number 03229487
Status Pending
Filing Date 2022-08-22
Open to Public Date 2023-02-23
Owner
  • THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (USA)
  • THE GOVERNMENT OF THE UNITED STATES, (USA)
Inventor
  • Waickman, Adam
  • Wegman, Adam
  • Currier, Jeffrey
  • Friberg, Heather
  • Mccracken, Michael
  • Gromowski, Gregory

Abstract

The present disclosure relates to IgA antibodies and antigen binding fragments thereof and to cocktails of antibodies and antigen binding fragments that neutralize virus infection without contributing to antibody-dependent enhancement of dengue virus infection. The present disclosure also relates to immortalized B cells that produce, and to epitopes that bind to, such antibodies and antigen binding fragments.

IPC Classes  ?

  • A61P 31/14 - Antivirals for RNA viruses
  • C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
  • C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses

3.

MONOCLONAL ANTIBODIES AGAINST CORONAVIRUSES AND USES THEREOF

      
Document Number 03203325
Status Pending
Filing Date 2022-01-24
Open to Public Date 2022-07-28
Owner
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
Inventor
  • Krebs, Shelly
  • Modjarrad, Kayvon
  • Michael, Nelson
  • Dussupt, Vincent
  • Donofrio, Gina C.
  • Townsley, Samantha

Abstract

The present disclosure is directed to monoclonal antibodies, or antigen-binding fragments thereof, that bind to coronavirus spike proteins, including the spike protein of SARS-CoV-2. These antibodies demonstrate high affinity binding to epitopes on the coronavirus spike protein and/or broad cross-reactivity to the spike protein of various coronaviruses. Compositions comprising the anti-coronavirus antibodies, nucleic acids encoding for the antibodies, recombinant expression vectors, and host cells are also disclosed. The present disclosure is also directed to methods of diagnosing, preventing or treating coronavirus infections, including infections or disease caused by SARS-CoV-2.

IPC Classes  ?

  • A61K 39/42 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum viral
  • A61P 31/14 - Antivirals for RNA viruses
  • C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
  • C07K 16/46 - Hybrid immunoglobulins
  • C12N 15/13 - Immunoglobulins
  • G01N 33/577 - ImmunoassayBiospecific binding assayMaterials therefor involving monoclonal antibodies

4.

THERMOGENIC AIRWAY MANAGEMENT DEVICE AND METHODS

      
Document Number 03200085
Status Pending
Filing Date 2021-11-30
Open to Public Date 2022-06-09
Owner THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor
  • Pierce, Bradley T.
  • Stevens, Ryan A.
  • Tilley, Laura C.

Abstract

A thermogenic emergency airway management device configured to prevent or treat hypothermia in a patient. The device may be configured to receive ambient air and modify one or more properties of the ambient air to output air at a temperature and/or humidity associated with the prevention and/or treatment of hypothermia. In an embodiment, the device may receive input via a user interface to determine a temperature and/or humidity associated with the air to be output to the patient. In an embodiment, the input may additionally include an amount of air to be output to be the patient. In such an embodiment, the device may be configured to cause the amount of air to be output to the patient to prevent and/or treat hypothermia.

IPC Classes  ?

  • A61M 16/10 - Preparation of respiratory gases or vapours
  • A61M 16/12 - Preparation of respiratory gases or vapours by mixing different gases
  • A61M 16/20 - Valves specially adapted to medical respiratory devices

5.

CATHEPSIN INHIBITORS FOR PREVENTING OR TREATING VIRAL INFECTIONS

      
Document Number 03173172
Status Pending
Filing Date 2021-03-26
Open to Public Date 2021-09-30
Owner
  • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (United Kingdom)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor
  • Kane, Christopher D.
  • Soloveva, Veronica
  • Bavari, Sina
  • Peat, Andrew James

Abstract

Provided are cathepsin inhibitor compounds and pharmaceutically acceptable salts thereof, and combinations thereof, for use in the treatment or prophylaxis of viral disease in an animal.

IPC Classes  ?

  • A61K 31/55 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
  • A61P 31/14 - Antivirals for RNA viruses

6.

VACCINES AGAINST SARS-COV-2 AND OTHER CORONAVIRUSES

      
Document Number 03170575
Status Pending
Filing Date 2021-03-08
Open to Public Date 2021-09-10
Owner
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
Inventor
  • Joyce, Michael Gordon
  • Modjarrad, Kayvon

Abstract

The present disclosure relates to the field of vaccines and binding molecules, as well as preparations and methods of their use in the treatment and/or prevention of disease. Described are vaccines and binding molecules, compositions containing the same, and uses thereof for treating or preventing coronavirus infections, in particular, ?-coronaviruses such as SARS- CoV-2, the causative agent of COVID-19, as well as SARS-CoV-1 and other coronaviruses.

IPC Classes  ?

  • A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus

7.

FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE

      
Document Number 03167691
Status Pending
Filing Date 2021-01-13
Open to Public Date 2021-07-22
Owner
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (USA)
Inventor
  • Torres, Oscar
  • Matyas, Gary R.
  • Rice, Kenner C.
  • Bow, Eric W.
  • Sulima, Agnieszka
  • Jacobson, Arthur E.

Abstract

Described is the preparation of novel fentanyl haptens of Formula (1) through (6) and their use in the preparation of effective fentanyl vaccines.

IPC Classes  ?

  • A61K 31/4468 - Non-condensed piperidines, e.g. piperocaine having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl
  • A61P 25/36 - Opioid-abuse
  • C07D 211/06 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
  • C07D 211/58 - Nitrogen atoms attached in position 4

8.

HEMOGLOBIN SUBSTITUTE MIXTURES INCLUDING RECONSTITUTED PLASMA AND PLATELETS AND THEIR MANUFACTURE AND USE

      
Document Number 03143968
Status Pending
Filing Date 2020-07-02
Open to Public Date 2021-02-25
Owner
  • HBO2 THERAPEUTICS, LLC (USA)
  • THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor
  • Dube, Gregory P.
  • Cap, Andrew P.
  • Meledeo, Michael A.

Abstract

A therapeutic hemoglobin-based oxygen carrier solution is formed by directly combining at least one of freeze-dried platelets and freeze-drug plasma with a hemoglobin-based oxygen carrier. The therapeutic hemoglobin-based oxygen carrier solution can be employed to treat bleeding or anemia and simultaneously increase systemic convective oxygen delivery in a subject suffering low circulatory oxygen transport or bleeding.

IPC Classes  ?

  • A61K 35/16 - Blood plasmaBlood serum
  • A61K 35/19 - PlateletsMegacaryocytes
  • A61K 38/42 - HaemoglobinsMyoglobins
  • A61K 47/02 - Inorganic compounds
  • A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61P 7/00 - Drugs for disorders of the blood or the extracellular fluid
  • A61P 7/04 - AntihaemorrhagicsProcoagulantsHaemostatic agentsAntifibrinolytic agents
  • A61P 7/06 - Antianaemics
  • A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

9.

POTENT ZIKA VIRUS-SPECIFIC AND CROSS-NEUTRALIZING MONOCLONAL ANTIBODIES TO ZIKA AND DENGUE VIRUSES FOLLOWING ZIKV INFECTION OR VACCINATION

      
Document Number 03098373
Status Pending
Filing Date 2019-04-24
Open to Public Date 2019-10-31
Owner
  • THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (USA)
  • THE BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (USA)
  • THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor
  • Krebs, Shelly
  • Donofrio, Gina
  • Dussupt, Vincent
  • Modjarrad, Kayvon
  • Barouch, Dan
  • Jarman, Iii, Richard G.
  • Michael, Nelson L.
  • Joyce, Gordon
  • Sankhala, Rajeshwer Singh
  • Stephenson, Kathryn Elaine

Abstract

The invention described herein provides antibodies to Zika virus. The novel polypeptides are useful alone or as portions of larger molecules, such as antibodies or antibody fragments, that can be used to treat or prevent infection of Zika virus.

IPC Classes  ?

  • A61K 39/42 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum viral
  • A61P 31/14 - Antivirals for RNA viruses
  • C07K 1/22 - Affinity chromatography or related techniques based upon selective absorption processes
  • C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
  • C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
  • C07K 16/46 - Hybrid immunoglobulins
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 15/13 - Immunoglobulins
  • C12P 21/08 - Monoclonal antibodies
  • G01N 33/569 - ImmunoassayBiospecific binding assayMaterials therefor for microorganisms, e.g. protozoa, bacteria, viruses

10.

ALUMINUM BASED NANOGALVANIC COMPOSITIONS USEFUL FOR GENERATING HYDROGEN GAS AND LOW TEMPERATURE PROCESSING THEREOF

      
Document Number 03070221
Status In Force
Filing Date 2018-07-23
Open to Public Date 2019-01-31
Grant Date 2023-10-10
Owner UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor
  • Darling, Kristopher Allen
  • Giri, Anit Kumar
  • Hornbuckle, Billy Chad
  • Roberts, Anthony James
  • Grendahl, Scott Martin

Abstract

Alloys comprised of a refined microstructure, ultrafine or nano scaled, that when reacted with water or any liquid containing water will spontaneously and rapidly produce hydrogen at ambient or elevated temperature are described. These metals, termed here as aluminum based nanogalvanic alloys will have applications that include but are not limited to energy generation on demand. The alloys may be composed of primarily aluminum and other metals e.g. tin bismuth, indium, gallium, lead, etc. and/or carbon, and mixtures and alloys thereof. The alloys may be processed by ball milling for the purpose of synthesizing powder feed stocks, in which each powder particle will have the above mentioned characteristics. These powders can be used in their inherent form or consolidated using commercially available techniques for the purpose of manufacturing useful functional components.

IPC Classes  ?

  • C22C 21/00 - Alloys based on aluminium
  • E21B 23/06 - Apparatus for displacing, setting, locking, releasing or removing tools, packers or the like in boreholes or wells for setting packers
  • E21B 33/12 - PackersPlugs

11.

METHOD OF CREATING A FRAGMENTATION PATTERN ON A WARHEAD

      
Document Number 03018478
Status Pending
Filing Date 2017-03-29
Open to Public Date 2017-10-05
Owner U.S. GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor
  • Manz, Paul C.
  • Magnotti, Phillip J.
  • Nguyen, Ductri H.

Abstract

A method of creating a fragmentation pattern on a warhead comprising ablating material from the interior surface of the warhead according to a pre-defined fragmentation pattern. The pre-defined fragmentation pattern may be effected electronically or with a mask. The ablation may be effected by applying an etchant to the warhead interior surface material.

IPC Classes  ?

  • F42B 12/24 - Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect of high-explosive type with fragmentation-hull construction with grooves, recesses or other wall weakenings
  • F42B 12/32 - Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect of high-explosive type with fragmentation-hull construction the hull or case comprising a plurality of discrete bodies, e.g. steel balls, embedded therein
  • F42B 33/00 - Manufacture of ammunitionDismantling of ammunitionApparatus therefor

12.

OMNIDIRECTIONAL ANTENNA SYSTEM

      
Document Number 02923240
Status In Force
Filing Date 2016-03-08
Open to Public Date 2016-12-04
Grant Date 2021-04-20
Owner
  • THE BOEING COMPANY (USA)
  • GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor
  • Lavin, Ronald O.
  • Lee, Andy H.
  • Pyle, Glenn T.
  • Robeson, Mark E.

Abstract

An antenna system may include a first antenna, and a second antenna opposite the first antenna, wherein the first antenna and the second antenna are configured to provide omnidirectional coverage

IPC Classes  ?

  • B64G 1/66 - Arrangements or adaptations of apparatus or instruments, not otherwise provided for
  • H01Q 1/44 - Details of, or arrangements associated with, antennas using equipment having another main function to serve additionally as an antenna
  • H01Q 21/22 - Antenna units of the array energised non-uniformly in amplitude or phase, e.g. tapered array or binomial array
  • H01Q 21/29 - Combinations of different interacting antenna units for giving a desired directional characteristic

13.

REGIMENS OF TAFENOQUINE FOR PREVENTION OF MALARIA IN MALARIA-NAIVE SUBJECTS

      
Document Number 02968694
Status In Force
Filing Date 2015-12-02
Open to Public Date 2016-06-09
Grant Date 2023-06-13
Owner
  • THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • 60 DEGREES PHARMACEUTICALS, LLC (USA)
Inventor
  • Jones, John P.
  • Shmuklarsky, Moshe
  • Budda, Balasubrahmanyam
  • Dow, Geoffrey S.
  • Smith, Bryan L.

Abstract

Methods of prevention of symptomatic malaria in a malaria-naïve, G6PD-normal human subject comprising administering to the human subject a compound of Formula (I), a pharmaceutically acceptable salt thereof, or pharmaceutical composition comprising a compound of Formula (I). A compound of Formula (I) can be administered prior to potential exposure of a species of Plasmodium, during potential exposure of a species of Plasmodium, and after potential exposure of a species of Plasmodium. The methods of the invention also pertains to kits comprising specific doses of Formula (I), a pharmaceutically acceptable salt thereof, or pharmaceutical composition comprising a compound of Formula (I), and instructions for administration of dosing quantity and frequency. The methods of the invention also pertain to determining doses of Formula (I) that meet the general regulatory requirement for a drug to be efficacious in the prevention of malaria in malaria-naïve subjects. The methods of the invention further pertain to using the described algorithm to derive dosing regimens which can provide protection against symptomatic malaria in malaria-naïve, G6PD-normal subjects.

IPC Classes  ?

14.

A MECHANICAL TOURNIQUET APPARATUS AND METHOD OF USE

      
Document Number 03214534
Status Pending
Filing Date 2014-09-29
Open to Public Date 2015-04-02
Owner
  • GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • ALPHAPOINTE (USA)
Inventor
  • Kosiorek, Christopher B.
  • Drayton, Dexter C.
  • Abir, Esra
  • Damar, Neslihan
  • Polat, Nilufer
  • Avci, Yavuz

Abstract

ABSTRACTA pre-fabricated tourniquet that is easy to apply, that ensures consistent and even circumferential pressure, that is light weight, that provides standard life saving operation, and that can be utilized in any setting or situation, and related methods are provided. Mechanically constricting tourniquet apparatus and related methods are provided that are comprised of a tourniquet body, a carriage, a torsion bar, a receiver and a slider. The tourniquet is long enough to encircle a human limb, for example, an arm or leg.Date recue/Date received 2023-09-27

IPC Classes  ?

  • A61B 17/00 - Surgical instruments, devices or methods
  • A61B 17/132 - Tourniquets
  • A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges

15.

A MECHANICAL TOURNIQUET APPARATUS AND METHOD OF USE

      
Document Number 02929223
Status In Force
Filing Date 2014-09-29
Open to Public Date 2015-04-02
Grant Date 2023-10-31
Owner
  • GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • ALPHAPOINTE (USA)
Inventor
  • Kosiorek, Christopher B.
  • Abir, Esra
  • Damar, Neslihan
  • Polat, Nilufer
  • Avci, Yavuz
  • Drayton, Dexter C.

Abstract

A pre-fabricated tourniquet that is easy to apply, that ensures consistent and even circumferential pressure, that is light weight, that provides standard life saving operation, and that can be utilized in any setting or situation, and related methods are provided. Mechanically constricting tourniquet apparatus and related methods are provided that are comprised of a tourniquet body, a carriage, a torsion bar, a receiver and a slider. The tourniquet is long enough to encircle a human limb, for example, an arm or leg.

IPC Classes  ?

16.

ESTIMATING CORE TEMPERATURES OF BATTERY CELLS IN A BATTERY PACK

      
Document Number 02874632
Status In Force
Filing Date 2013-05-23
Open to Public Date 2013-11-28
Grant Date 2021-06-22
Owner
  • UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (THE) (USA)
  • THE REGENTS OF THE UNIVERSITY OF MICHIGAN (USA)
Inventor
  • Lin, Xinfan
  • Stefanopoulou, Anna G.
  • Ding, Yi
  • Castanier, Matthew P.

Abstract

A method and a system of estimating core temperatures of battery cells in a battery pack can include several steps. In one step, a surface temperature of one or more battery cell(s) is received, a current of the one or more battery cell(s) is received, an inlet temperature of coolant provided to the battery pack is received, and a flow rate or velocity of the coolant is received. In another step, estimations are made including those of a cell-lumped internal electrical resistance of the battery cell(s), a cell-lumped conduction resistance between a core and a surface of the battery cell(s), and a cell- lumped convection resistance between the surface and the coolant. In yet another step, an estimation is made of a core temperature of the battery cell(s) based upon the received and estimated values of previous steps.

IPC Classes  ?

  • H01M 10/48 - Accumulators combined with arrangements for measuring, testing or indicating the condition of cells, e.g. the level or density of the electrolyte

17.

CEMENT BASED ARMOR PANEL SYSTEM

      
Document Number 02716969
Status In Force
Filing Date 2009-02-27
Open to Public Date 2009-09-11
Grant Date 2015-06-09
Owner
  • UNITED STATES GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • Knauf Gips KG (USA)
Inventor
  • Tonyan, Timothy D.
  • Frank, William A.
  • Dubey, Ashish
  • Natesaiyer, Kumar
  • Durst, Bartley P.
  • Kinnebrew, Pamela G.
  • Cummins, Toney K.
  • Boone, Nicholas
  • Heard, William F.
  • Roth, Michael J.
  • Slawson, Thomas
  • Davis, James L.
  • Stinson, Ryan
  • Johnson, Carol F.

Abstract

A cementitious armor panel assembly including cementitious armor panel with ballistic and blast resistant properties attached to a frame structure to produce a protective structure. The cementitious armor panels have a continuous phase resulting from the curing of an aqueous mixture of an inorganic cement binder, an inorganic mineral filler having a particle size of about 150-450 microns, a pozzolanic mineral filler, a polycarboxylate based super-plasticizer self-leveling agent, and water. The mixture may also contain alkanolamine, and acid or acid salt. Prior to curing, the continuous phase is reinforced with fiber uniformly distributed in the continuous phase before it is cured to form the panel. The panel may be reinforced with a skin attached to at least one surface of the panel.

IPC Classes  ?

  • C04B 28/28 - Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing organic polyacids, e.g. polycarboxylate cements
  • F41H 5/02 - Plate construction
  • F41H 5/04 - Plate construction composed of more than one layer

18.

CEMENT BASED LAMINATED ARMOR PANELS

      
Document Number 02717506
Status In Force
Filing Date 2009-02-27
Open to Public Date 2009-09-11
Grant Date 2015-11-24
Owner
  • UNITED STATES GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • Knauf Gips KG (USA)
Inventor
  • Tonyan, Timothy D.
  • Frank, William A.
  • Dubey, Ashish
  • Chan, Cesar
  • Durst, Bartley P.
  • Kinnebrew, Pamela G.
  • Cummins, Toney K.
  • Boone, Nicholas
  • Heard, William F.
  • Roth, Michael J.
  • Davis, James L.

Abstract

A cementitious panel with ballistic and blast resistant properties having a core layer of ultra-high compressive strength composite and at least one skin layer. The panels can also be used in walls, ceiling and flooring panels which require high compressive strength for resistance to earthquakes and surfaces resistant to surface abuse such as in prison and other institutions. The panel core layer has a continuous cementitious phase resulting from the curing of an aqueous mixture, in the absence of silica flour, of inorganic cement binder, inorganic mineral filler having a particle size of about 150-450 microns, a pozzolanic mineral filler, polycarboxylate based superplasticizer, alkanolamine and acid or alkali metal acid salt; and water. The mixture may be uniformly reinforced with fiber added before curing. The cementitious core layer is then reinforced with the skin, such as fiber reinforced polymer, attached to at least one panel surface.

IPC Classes  ?

  • B32B 7/12 - Interconnection of layers using interposed adhesives or interposed materials with bonding properties
  • B32B 13/12 - Layered products essentially comprising a water-setting substance, e.g. concrete, plaster, asbestos cement, or like builders' material comprising such substances as the main or only constituent of a layer, next to another layer of a specific substance of synthetic resin
  • B32B 13/14 - Layered products essentially comprising a water-setting substance, e.g. concrete, plaster, asbestos cement, or like builders' material next to a fibrous or filamentary layer
  • F41H 5/04 - Plate construction composed of more than one layer

19.

A SELF-LEVELING CEMENTITIOUS COMPOSITION WITH CONTROLLED RATE OF STRENGTH DEVELOPMENT AND ULTRA-HIGH COMPRESSIVE STRENGTH UPON HARDENING AND ARTICLES MADE FROM SAME

      
Document Number 02717507
Status In Force
Filing Date 2009-02-27
Open to Public Date 2009-09-11
Grant Date 2015-09-15
Owner
  • UNITED STATES GOVERNMENT, REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
  • Knauf Gips KG (USA)
Inventor
  • Dubey, Ashish
  • Chan, Cesar
  • Natesaiyer, Kumar
  • Durst, Bartley P.
  • Kinnebrew, Pamela G.
  • Cummins, Toney K.
  • Boone, Nicholas
  • Heard, William F.
  • Roth, Michael J.
  • Slawson, Thomas

Abstract

A self-leveling cementitious mixture with excellent flow properties and which hardens with a controlled rate of strength development to an ultra-high compressive strength composite composition for use in making articles such as cementitious armor panel with ballistic and blast resistant properties including: a continuous phase resulting from the curing of an aqueous mixture, in the absence of silica flour, of inorganic cement binder, inorganic mineral filler having a particle size of about 150-450 microns, pozzolanic mineral filler, polycarboxylate based self-leveling agent and water. The cementitious mixture may include alkanolamine, such as thethanolamine, and acid or acid salt, such as tartaric acid. The cementitious composition may be reinforced with reinforcing fibers, e.g. glass fibers, in an amount of about 0.5 - 6.0 % by volume of the overall cementitious composition. The fibers are uniformly dispersed in the cementitious composition before it is cured to form a final cementitious armor panel.

IPC Classes  ?

  • C04B 14/02 - Granular materials
  • C04B 14/38 - Fibrous materialsWhiskers
  • C04B 28/00 - Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements

20.

TRAUMA TRAINING SYSTEM

      
Document Number 02650540
Status In Force
Filing Date 2007-04-24
Open to Public Date 2007-11-08
Grant Date 2015-06-16
Owner U.S. GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (USA)
Inventor King, Lynn R.

Abstract

A system for simulating one or more hemorrhages in order to provide a more dynamic and realistic hemorrhage simulation in order to train medical personnel and other critical care givers, such as first responders, medics, and emergency medical technicians (EMTs) on treating hemorrhages. The system includes a reservoir, a flow controller, and at least one conduit connected to at least one simulated wound site wherein the system supplies fluid to the simulated wound site in order to simulate a hemorrhage. The system may further include a plurality of wound sites that have their respective fluid flows controlled by the fluid flow controller. In at least one embodiment, the reservoir and the flow controller are housed within a bag. In at least one embodiment, the system further includes an audio system for providing audio cues to the simulation participants to enhance the realism of the simulation.

IPC Classes  ?